BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3752695)

  • 1. Neutralization of African swine fever virus by sera from African swine fever-resistant pigs.
    Ruiz Gonzalvo F; Caballero C; Martinez J; Carnero ME
    Am J Vet Res; 1986 Aug; 47(8):1858-62. PubMed ID: 3752695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. African Swine Fever Virus Host-Pathogen Interactions.
    Netherton CL; Shimmon GL; Hui JYK; Connell S; Reis AL
    Subcell Biochem; 2023; 106():283-331. PubMed ID: 38159232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of African Swine Fever Virus.
    Shimmon GL; Shah PNM; Fry E; Stuart DI; Hawes P; Netherton CL
    Methods Mol Biol; 2022; 2503():179-186. PubMed ID: 35575895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Li et al. African Swine Fever Virus: A Review.
    Li Z; Chen W; Qiu Z; Li Y; Fan J; Wu K; Li X; Zhao M; Ding H; Fan S; Chen J
    Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The African Fever.
    Med Exam (Phila); 1846 Jan; 2(13):69. PubMed ID: 38120148
    [No Abstract]   [Full Text] [Related]  

  • 6. Virulent African swine fever virus isolates are neutralized by swine immune serum and by monoclonal antibodies recognizing a 72-kDa viral protein.
    Zsak L; Onisk DV; Afonso CL; Rock DL
    Virology; 1993 Oct; 196(2):596-602. PubMed ID: 7690502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riding apoptotic bodies for cell-cell transmission by African swine fever virus.
    Gao P; Zhou L; Wu J; Weng W; Wang H; Ye M; Qu Y; Hao Y; Zhang Y; Ge X; Guo X; Han J; Yang H
    Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2309506120. PubMed ID: 37983498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Attenuated and Virulent Strains of African Swine Fever Virus Genotype I and Serogroup 2.
    Kholod N; Koltsov A; Krutko S; Tulman ER; Namsrayn S; Kutish GF; Belov S; Korotin A; Sukher M; Koltsova G
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.
    Zhu JJ
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression in monocytes of immunized pigs after infection with homologous or heterologous African swine fever virus.
    Kholod N; Koltsov A; Koltsova G
    Front Vet Sci; 2022; 9():936978. PubMed ID: 36032295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Neutralizing and Enhancing Effects on African Swine Fever Virus Infectivity in Adherent Pig PBMC.
    Canter JA; Aponte T; Ramirez-Medina E; Pruitt S; Gladue DP; Borca MV; Zhu JJ
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates.
    Gladue DP; Borca MV
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Escape Mechanism and Vaccine Research Progress of African Swine Fever Virus.
    Wang Z; Ai Q; Huang S; Ou Y; Gao Y; Tong T; Fan H
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and immunogenic properties of recombinant proteins consisting of two immunodominant African swine fever virus proteins fused with bacterial lipoprotein OprI.
    Zhang G; Liu W; Gao Z; Chang Y; Yang S; Peng Q; Ge S; Kang B; Shao J; Chang H
    Virol J; 2022 Jan; 19(1):16. PubMed ID: 35062983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses.
    Barasona JA; Cadenas-Fernández E; Kosowska A; Barroso-Arévalo S; Rivera B; Sánchez R; Porras N; Gallardo C; Sánchez-Vizcaíno JM
    Front Immunol; 2021; 12():761753. PubMed ID: 34917082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A QP509L/QP383R-Deleted African Swine Fever Virus Is Highly Attenuated in Swine but Does Not Confer Protection against Parental Virus Challenge.
    Li D; Wu P; Liu H; Feng T; Yang W; Ru Y; Li P; Qi X; Shi Z; Zheng H
    J Virol; 2022 Jan; 96(1):e0150021. PubMed ID: 34613824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M448R and MGF505-7R: Two African Swine Fever Virus Antigens Commonly Recognized by ASFV-Specific T-Cells and with Protective Potential.
    Bosch-Camós L; López E; Collado J; Navas MJ; Blanco-Fuertes M; Pina-Pedrero S; Accensi F; Salas ML; Mundt E; Nikolin V; Rodríguez F
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34069239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoughts on African Swine Fever Vaccines.
    Rock DL
    Viruses; 2021 May; 13(5):. PubMed ID: 34065425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 Strain.
    Sunwoo SY; Pérez-Núñez D; Morozov I; Sánchez EG; Gaudreault NN; Trujillo JD; Mur L; Nogal M; Madden D; Urbaniak K; Kim IJ; Ma W; Revilla Y; Richt JA
    Vaccines (Basel); 2019 Jan; 7(1):. PubMed ID: 30696015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.
    Arias M; de la Torre A; Dixon L; Gallardo C; Jori F; Laddomada A; Martins C; Parkhouse RM; Revilla Y; Rodriguez FAJ;
    Vaccines (Basel); 2017 Oct; 5(4):. PubMed ID: 28991171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.